Rhythm Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
RYTM Key Statistics
Stock Snapshot
As of today, Rhythm Pharmaceuticals(RYTM) shares are valued at $99.78. The company's market cap stands at 6.66B, with a P/E ratio of -32.15.
On 2026-02-23, Rhythm Pharmaceuticals(RYTM) stock traded between a low of $97.15 and a high of $103.52. Shares are currently priced at $99.78, which is +2.7% above the low and -3.6% below the high.
Rhythm Pharmaceuticals(RYTM) shares are trading with a volume of 641.65K, against a daily average of 718.36K.
During the past year, Rhythm Pharmaceuticals(RYTM) stock moved between $45.91 at its lowest and $122.20 at its peak.
During the past year, Rhythm Pharmaceuticals(RYTM) stock moved between $45.91 at its lowest and $122.20 at its peak.
RYTM News
RBC Capital Markets initiated coverage on Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) , citing it as a commercial-stage biotech pioneering the rare genetic obesit...
